Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 660

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The distinctive biology of cancer in adolescents and young adults

on behalf of the Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology, Bleyer, Archie, Barr, Ronald, Hayes-Lattin, Brandon, Thomas, David, Ellis, Chad, Anderson, Barry · 2008 · Nature Reviews Cancer

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrc2349

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 21

  1. Schmidt, C. Lack of progress in teen and young adult cancers concerns researchers, prompts study. J. Natl Cancer Inst 98, 1760–1761 (2006). · doi:10.1093/jnci/djj517
  2. Closing the gap: Research and care imperatives for adolescents and young adults with cancer. A report of the Adolescent and Young Adult Oncology Progress Review Group. Department of Health and Human Services, National Institutes of Health, National Cancer Institute and the LiveStrong Young Adult Alliance. National Cancer Institute [online] , (2006). The final report from the Progress Review Group convened by the National Institutes of Health to address the challenges of adolescent and young adult oncology.
  3. LiveStrong Young Adult Alliance. Closing the Gap: A Strategic Plan. Addressing the Recommendations of the Adolescent and Young Adult Progress Review Group. (Lance Armstrong Foundation, Austin 2007). The response from the Young Adult Alliance to the recommendations of the Progress Review Group, in the form of a strategic plan for implementation.
  4. Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S. & Pawel, B. Chemotherapy intensification by interval compression in localized Ewing sarcoma family of tumors (ESFT). Proc. 13th Ann. Meeting Connective Tissue Oncol. Soc. 31 October–3 November 2008, Seattle, Washington, USA. Abstract 855.
  5. Kalapurakal, J. A. et al. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int. J. Radiat. Oncol. Biol. Phys. 60, 1379–1384 (2004). · doi:10.1016/j.ijrobp.2004.05.057
  6. Kushner, B. H., Kramer, K., LaQuaglia, MP., Modak, S. & Cheung, N. K. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Med. Pediatr. Oncol. 41, 508–515 (2003). · doi:10.1002/mpo.10273
  7. Anderson, W. F., Brinton, L. A., Chen, B. & Devesa, S. S. Qualitative age interactions (or effect modification) suggest divergent pathways for early-onset and late-onset breast cancers. J. Clin. Oncol. 25, 21036a (2007). · doi:10.1200/jco.2007.25.18_suppl.21036
  8. Kam, M. H., Eu, K. W., Barben, C. P. & Seow-Choen, F. Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis. 6, 191–194 (2004). · doi:10.1111/j.1463-1318.2004.00596.x
  9. Al-Jaberi, T. M., Yaghan, R. J., El-Heis, H. A. Colorectal cancer in young patients under 40 years of age. Comparison with old patients in a well defined Jordanian population. Saudi Med. J. 8, 871–874 (2003).
  10. Ferrari A et al. Colorectal carcinoma in children and adolescents: The experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr. Blood Cancer 50, 588–593 (2008). · doi:10.1002/pbc.21220
  11. Kanerva, J. et al. Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 33, 388–394 (1999). · doi:10.1002/(sici)1096-911x(199910)33:4<388::aid-mpo8>3.0.co;2-n
  12. Möricke, A. et al. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: Data from the Trials ALL-BFM 86, 90, and 95. Klin. Pädiatr 217, 310–320 (2005). · doi:10.1055/s-2005-872515
  13. Hoelzer, D. Advances in the management of Ph-positive ALL. Clin. Adv. Hematol. Oncol. 4, 804–805 (2006).
  14. Gutierrez, M. I., Siraj, A. K., Ibrahim, M. M., Hussain, A. & Bhatia, K. Childhood and adult ALL: differences in epigenetic lesions associated with cell cycle genes. Am. J. Hematol. 80, 158–160 (2005). · doi:10.1002/ajh.20458
  15. Schroeder, H. et al. Prognosis of ALL in 10–20 year old patients in Denmark 1992–2001. Pediatr. Blood Cancer 45, 578a (2005).
  16. Oschlies, I. et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: A clinicopathologic analysis of cases included in the German BFM (Berlin–Frankfurt–Münster) Multicenter Trial. Blood. 107, 4047–4052 (2006). · doi:10.1182/blood-2005-10-4213
  17. Pappo, A. S., Helman, I. J. & Furman, W. L. Rare cancers in children: When adult tumors occur in children. ASCO 2006 Education Book (2006).
  18. Prokurat, A. et al. Transitional liver cell tumors in older children and adolescents: A novel group of aggressive hepatic tumors expressing b-catenin. Med. Pediatr. Oncol. 39, 510–518 (2002). · doi:10.1002/mpo.10177
  19. Lu, K. et al. Prospective determination of prevalence of Lynch Syndrome in young women with endometrial cancer. J. Clin. Oncol. 25, 5158–5164 (2007). · doi:10.1200/jco.2007.10.8597
  20. Bürger, B. et al. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) — experiences from trial ALL-BFM 95. Pediatr. Blood Cancer 49, 764. (2007). · doi:10.1002/pbc.21141
  21. Aricò, M. et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88, 747–753 (2003).

Cited by

See all 660

Metadata

Authors
on behalf of the Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology, Bleyer, A., Barr, R., Hayes-Lattin, B., Thomas, D., Ellis, C., & Anderson, B.
Venue
Nature Reviews Cancer
Published
2008-04
Volume
8
Issue
4
Pages
288-298
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W1991401391
Cited by
660
References
39
FWCI
3.68
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.